David Lawrence, Chief, Business Operations & PAO at ACORDA THERAPEUTICS INC (ACOR), sold 250 shares at $20.82 ($5K) on 2016-10-07, disclosed to the SEC on 2016-10-11.
Scheduled sale ($5k) by Chief, Business Operations & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |